Page last updated: 2024-08-25

rosiglitazone and lobaric acid

rosiglitazone has been researched along with lobaric acid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azelmat, J; Barbeau, X; Carpentier, C; Grenier, D; Lagüe, P; Vaillancourt, K; Voyer, N	1

Other Studies

1 other study(ies) available for rosiglitazone and lobaric acid

Article	Year
Lobaric acid and pseudodepsidones inhibit NF-κB signaling pathway by activation of PPAR-γ. Bioorganic & medicinal chemistry, 2018, 12-01, Volume: 26, Issue:22 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Depsides; Dose-Response Relationship, Drug; Humans; Lactones; Lichens; Lipopolysaccharides; Macrophages; Molecular Docking Simulation; Molecular Structure; NF-kappa B; PPAR gamma; Salicylates; Signal Transduction; Structure-Activity Relationship; U937 Cells	2018

Article

Year

Lobaric acid and pseudodepsidones inhibit NF-κB signaling pathway by activation of PPAR-γ.

Bioorganic & medicinal chemistry, 2018, 12-01, Volume: 26, Issue:22

Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Depsides; Dose-Response Relationship, Drug; Humans; Lactones; Lichens; Lipopolysaccharides; Macrophages; Molecular Docking Simulation; Molecular Structure; NF-kappa B; PPAR gamma; Salicylates; Signal Transduction; Structure-Activity Relationship; U937 Cells

2018